Latest Period
Q2 2026
Security Snapshot
Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) Institutional Ownership
CUSIP: 413197104
13F Institutional Holders and Ownership History from Q3 2020 to Q2 2026
Institutions Reporting
326
Shares (Excl. Options)
54,178,562
Price
$36.41
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- HRMY on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 54,178,562
- Total 13F value
- $1,970,662,424
- Portfolio coverage rank
- 0%
- Share change
- -1,768,640
- Value change
- -$50,507,859
- Number of holders
- 326
- Shares outstanding
- 57,940,610
- SEC-reported price per share
- $33.77
- Insider filing price
- $33.77
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- HRMY - Harmony Biosciences Holdings, Inc. - Common Stock is tracked under CUSIP 413197104.
- 326 institutions reported positions in Q2 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 311 to 326 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $1,568,367,760 to $1,970,662,424.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 326 institutions filings for Q2 2026.
Security key
413197104
Latest holder period
Q2 2026
13F holders
326
13D/G owners
4
CIK / CUSIP context first
Open Q2 2026 holders
HRMY full holder history
Harmony Biosciences Holdings, Inc. SEC filings
Harmony Biosciences Holdings, Inc. company facts
Harmony Biosciences Holdings, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 413197104:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
HRMY
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 11% | +12% | $237,599,390 | +$27,550,901 | 6,525,663 | +13% | BlackRock, Inc. | 30 Jun 2026 |
| Marshman Fund Trust II | 11% | $178,084,462 | 6,051,120 | Marshman Fund Trust II | 31 Dec 2024 | |||
| FMR LLC | 5.4% | -19% | $116,481,431 | -$27,472,267 | 3,112,812 | -19% | FMR LLC | 31 Dec 2025 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.1% | $104,607,832 | 2,943,383 | Vanguard Portfolio Management | 30 Jun 2026 |
As of 30 Jun 2026, 326 institutional investors reported holding 54,178,562 shares of Harmony Biosciences Holdings, Inc. - Common Stock (HRMY). This represents 94% of the company’s total 57,940,610 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
66%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 12% | 7,101,965 | +0.45% | 0% | $258,582,545 |
| FMR LLC | 6.2% | 3,574,115 | +13% | 0.01% | $130,133,520 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5% | 2,880,489 | +6.1% | 0% | $104,878,604 |
| AMERICAN CENTURY COMPANIES INC | 4.4% | 2,539,512 | +21% | 0.04% | $92,463,632 |
| DIMENSIONAL FUND ADVISORS LP | 4.1% | 2,393,588 | +15% | 0.02% | $87,144,817 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.6% | 2,105,053 | +0.13% | 0% | $76,644,980 |
| LSV ASSET MANAGEMENT | 3.6% | 2,061,242 | +1.8% | 0.14% | $75,050,000 |
| STATE STREET CORP | 3.2% | 1,859,322 | +4.2% | 0% | $67,697,914 |
| ARMISTICE CAPITAL, LLC | 2.7% | 1,564,000 | -3.7% | 1.6% | $56,945,240 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.5% | 1,442,649 | +9.1% | 0% | $52,534,476 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2.3% | 1,312,550 | -5% | 0.02% | $47,789,946 |
| RENAISSANCE TECHNOLOGIES LLC | 2.1% | 1,195,371 | +11% | 0.06% | $43,523,458 |
| TWO SIGMA INVESTMENTS, LP | 1.7% | 959,136 | +31% | 0.03% | $34,922,142 |
| AQR CAPITAL MANAGEMENT LLC | 1.6% | 934,326 | +30% | 0.01% | $34,018,811 |
| SG Americas Securities, LLC | 1.5% | 882,720 | -56% | 0.02% | $32,140,000 |
| Valor Management LLC | 1.4% | 818,013 | +598% | 0.03% | $29,783,853 |
| MORGAN STANLEY | 1.3% | 733,684 | -29% | 0% | $26,713,449 |
| UBS Group AG | 1% | 602,990 | +35% | 0% | $21,954,865 |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 0.95% | 551,075 | -2.8% | 0.02% | $20,064,640 |
| Invesco Ltd. | 0.91% | 528,520 | -16% | 0% | $19,243,413 |
| JPMORGAN CHASE & CO | 0.89% | 514,085 | -38% | 0% | $18,247,739 |
| venBio Partners LLC | 0.81% | 472,194 | -3.5% | 3.3% | $17,192,584 |
| NORTHERN TRUST CORP | 0.81% | 471,221 | +11% | 0% | $17,157,157 |
| BNP PARIBAS FINANCIAL MARKETS | 0.76% | 438,302 | 0% | 0.01% | $15,958,576 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.73% | 423,824 | +3% | 0% | $15,431,432 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
24
Latest
Q2 2026
Rows shown
1-24 of 24
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 54,178,562 | $1,970,662,424 | -$50,507,859 | $36.41 | 326 |
| 2026 Q1 | 55,982,309 | $1,568,367,760 | +$132,481,383 | $28.01 | 311 |
| 2025 Q4 | 49,890,282 | $1,866,237,475 | +$93,866,889 | $37.42 | 323 |
| 2025 Q3 | 47,339,126 | $1,304,886,690 | -$112,498,749 | $27.56 | 292 |
| 2025 Q2 | 51,269,247 | $1,620,478,469 | +$22,306,889 | $31.60 | 276 |
| 2025 Q1 | 50,193,424 | $1,664,235,088 | -$100,697,267 | $33.19 | 267 |
| 2024 Q4 | 52,708,406 | $1,813,638,877 | +$62,320,767 | $34.41 | 244 |
| 2024 Q3 | 50,136,635 | $2,005,018,440 | +$11,121,046 | $40.00 | 231 |
| 2024 Q2 | 50,163,988 | $1,513,604,428 | +$34,652,893 | $30.17 | 218 |
| 2024 Q1 | 48,982,561 | $1,644,752,000 | +$41,053,934 | $33.58 | 206 |
| 2023 Q4 | 47,832,583 | $1,544,993,160 | -$51,074,763 | $32.30 | 219 |
| 2023 Q3 | 49,527,453 | $1,623,105,557 | -$85,461,798 | $32.77 | 203 |
| 2023 Q2 | 51,951,129 | $1,828,229,880 | +$28,751,282 | $35.19 | 207 |
| 2023 Q1 | 51,270,566 | $1,674,006,219 | -$29,571,258 | $32.65 | 213 |
| 2022 Q4 | 51,015,535 | $2,810,596,096 | +$34,893,529 | $55.10 | 238 |
| 2022 Q3 | 50,461,165 | $2,237,024,113 | +$91,703,030 | $44.29 | 195 |
| 2022 Q2 | 47,874,920 | $2,335,182,718 | +$99,684,851 | $48.77 | 173 |
| 2022 Q1 | 45,933,803 | $2,235,023,234 | +$79,981,090 | $48.65 | 168 |
| 2021 Q4 | 44,541,354 | $1,899,444,678 | +$107,131,256 | $42.64 | 138 |
| 2021 Q3 | 30,932,269 | $1,185,850,908 | +$116,456,188 | $38.33 | 99 |
| 2021 Q2 | 27,994,218 | $790,282,400 | -$7,611,822 | $28.23 | 79 |
| 2021 Q1 | 27,468,517 | $907,561,000 | -$18,485,709 | $33.04 | 55 |
| 2020 Q4 | 27,956,363 | $998,030,405 | -$18,654,367 | $36.15 | 59 |
| 2020 Q3 | 28,549,056 | $940,508,000 | +$940,508,000 | $33.90 | 44 |